Where can you spend three days in a world-class city surrounded by the global community of cardiovascular professionals and learn the latest and greatest in science and expand your clinical skills? In Washington, DC, – for ACC.17! Looking for the hottest new science that will drive the conversation in the hospitals and practices around the world? Be front and center to attend the 23 Late Breaking Clinical Trial presentations and the 17 Featured Clinical Research presentations. No doubt, these will include practice-changing information. The global exchange of science continues to drive the collaborative research that is unlocking the mysteries of cardiovascular disease and bringing forth the solutions to transform cardiovascular care and improve heart health. ACC.17 provides an unprecedented opportunity to foster this exchange, with 2,572 abstracts being presented in oral, poster, and expanded moderated poster sessions and presented by some 2,086 experts. Over 300 education sessions with 1,560 faculty have been designed to encourage discussion and debate about current and future cardiovascular trends and research. A cornerstone of the meeting is the active engagement amongst the participants that is created through the design of the interactive and innovative sessions and through the range of available networking opportunities. “This engagement is critical to providing meaningful education, and it is what makes ACC.17 different from other medical meetings,” says Jeffrey T. Kuvin, MD, FACC, chair of ACC.17. Members teaching members is another cornerstone of the annual scientific session of the College, and this is showcased at its finest in three Intensive sessions – each a concentrated exploration of its topic with ACC Talks and interactive features such as small group case simulations, case presentations and competitions (see sidebar). This ethos of members as teachers extends to development of the Fellows in Training and Early Career Professionals. “Nurturing the next generation is a core value of the ACC,” says Andrew M. Kates, MD, FACC, vice chair of ACC.17. As always, ACC.17 is also designed as a means for cardiovascular professionals to earn credit towards continuing education. Credit can be earned across the 11 Learning Pathways, each with oral (including a year in review) and poster abstract sessions, and in an environment that has enhanced audience participation and allows for interacting with thought leaders and colleagues. New this year is dual Maintenance of Certification (MOC)/Continuing Medical Education (CME) credit, which allows for simultaneous earning of a significant portion of both MOC and CME requirements. European CME credit for many sessions is available this year. The ACC supports the entire Cardiovascular Team and provides continuing education credit for nurses and pharmacists, too. In addition to education credit, the new Personal Skills Center provides self-paced learning, including an ECG Drill & Practice, Heart Songs, and case simulations across an expanded range of clinical scenarios. “The learner is at the center of their own education at ACC.17,” says Kates, whether through this new Center, or actively participating in the sessions. The re-designed ACC.17 app allows the learner to better customize their program and determine where to best spend their time by providing abstracts and other information to understand the session objectives and content beyond the title. The app also provides session slides to allow for preparing questions and taking notes with the slides during the presentation. Enhanced audience participation is the touchstone in most sessions, enabled in part through technology, with an interactive audience response system that allows learners to submit questions during a session for the moderator to pose to the experts and an audience polling tool. The named lectures – seven in all – bring a chance to gain a richer view of key topics in medicine today (see sidebar). The International program with its joint sessions held with our partner societies brings new insights into the shared problems of cardiovascular disease faced all around the world. Don’t miss the Engage Studio, the site of the ever-popular FIT Jeopardy competition – will the returning champion be the victor again? Networking is key at ACC.17 and the Lounge and Learn Pavilion has been re-designed with this in mind, offering a central location for cross-disciplinary interaction. ACC.17 is bringing the best in education and science packed into three focused days. It’s been designed to be informative, interactive, innovative, and interdisciplinary, and your best investment this year. “I’m excited we’re bringing together the global cardiovascular community and the entire cardiovascular team,” says Kuvin. “Friday’s Dack Lecture by David J. Skorton, MD, MACC, the secretary of the Smithsonian, along with the FOURIER, SPIRE and SURTAVI trial results are just the start to an amazing meeting,” says Kuvin. “Stay tuned, there is much, much more!” 2017 DISTINGUISHED AWARDEES Bernadine Healy Leadership in Women’s CV Disease Roxana Mehran, MD, FACC Distinguished Associate Kimberly K. Birtcher, PharmD, AACC Distinguished Fellow George P. Rodgers, MD, FACC Distinguished Mentor Cindy L. Grines, MD, FACC Distinguished Scientist (Basic Domain) Mark E. Josephson, MD, FACC Distinguished Scientist (Clinical Domain) William Tober Abraham, MD, FACC Distinguished Scientist (Translational Domain) Marc Alan Pfeffer, MD, PhD, FACC Distinguished Service Robert Louis Jesse, MD, PhD, FACC Distinguished Teacher George Dangas, MD, PhD, FACC Gifted Educator Ragavendra R. Baliga, MBBS, FACC International Service Ernest C. Madu, MBBS, FACC Lifetime Achievement Valentin Fuster, MD, PhD, MACC Presidential Citation Robert Guyton, MD, FACC Master of the ACC (MACC) Richard A. Chazal, MD, FACC Master of the ACC (MACC) Joseph P. Drozda, MD, FACC Master of the ACC (MACC) Barry J. Maron, MD, FACC Master of the ACC (MACC) Sidney C. Smith, Jr. MD, FACC ACC.17 FEATURED LECTURES Simon Dack Lecture David J. Skorton, MD, MACC Values: How the Arts and the Humanities Nurture our Careers and our Lives Friday, March 17, 8:00 – 10:00 a.m. Chatterjee Lecture and Seminal Talks in Heart Failure Mariell Jessup, MD, FACC Learning from Our Past and Looking to the Future – Hope for Heart Failure Friday, March 17, 12:15 – 1:45 p.m. Louis F. Bishop Lecture Janet S. Wright, MD, FACC Million Hearts: Results, Road Rash, and Lessons for Making More Progress, Faster Friday, March 17, 2:00 – 3:30 p.m. Douglas P. Zipes Young Scientist Awardee Lecture Steven Bradley, MD Ensuring Patients Receive the Right Therapy at the Right Time Saturday, March 18, 8:00 – 9:30 a.m. Maseri-Florio International Lecture Huon Gray, MD, FACC 16th Annual Maseri-Florio International Lecture: ACC International: An Overseas Perspective Saturday, March 18, 2:00 – 3:30 p.m. Dan G. McNamara Lecture Gail D. Pearson, MD, ScD, FACC NHLBI’s Investment in Pediatric Cardiovascular Research: Past, Present, and Future Sunday, March 19, 12:30 – 1:45 p.m. Eugene Braunwald Lecture on Future Directions in Cardiovascular Medicine Jeffrey M. Drazen, MD Data Sharing in Clinical Trials Sunday, March 19, 12:30 – 1:45 p.m. INTENSIVES FOCUS ON TEACHING WITH INTENT, HEALTH EQUITY AND PALLIATIVE CARE ACC Intensives are designed to target new and growing areas in cardiovascular practice and use gaps in competencies and knowledge to develop sessions that will expand attendees’ knowledge and understanding. Don’t miss this year’s unique, interactive half-day programs – each of which can be attended in full or in part. Teaching with Intent: Secrets from the Masters I, II and III Friday, March 17; 12:15 – 6:00 pm Learn how to prepare goals and objectives more effectively for Grand Rounds or similar situations; get tips on how to best prepare and deliver effective presentations; and participate in simulations and panel discussions using what you’ve learned. Are We There Yet? The Long Journey to Health Equity: Part I, II and III Saturday, March 18; 10:45 am – 3:30 pm Hear from experts on the current status of health equity; discuss the role of partnerships in achieving healthy equity in cardiovascular disease; and participate in discussions on what needs to be done socially, culturally, geographically and globally going forward. Palliative Care for the 99%: Part I and II Sunday, March 19; 10:45 am – 3:30 pm Get practical guidance on how to handle some of the difficult communication/care challenges in palliative care, including developing patient rapport, assessing and communicating prognosis, managing symptoms and delivering difficult information. STAY CONNECTED AT ACC.17 THROUGH SOCIAL MEDIA Stay connected at ACC.17 through social media channels. Follow @ACCCardioEd on Twitter and use the hashtag #ACC17 to join the conversation throughout the meeting. Visit ACC’s Facebook page to tag yourself in photos and read about the hottest science presented at the meeting on ACC.org/ACC2017 LOUNGE & LEARN PAVILION Check out the FIT, Early Career, Women in Cardiology, Cardiovascular Team, International and Cardiology Careers lounges at ACC.17 located in the Lounge & Learn Pavilion, Hall D. Many of the lounges will feature minieducational sessions, networking opportunities and career advancement opportunities. Don’t miss your chance to meet some of the biggest names in cardiology and learn about what the College is doing in your career focus area. Meet up with your colleagues, live stream sessions from the session rooms or participate in informal sessions in the various community lounges. ACC domestic members can also visit the ACC PAC lounge and learn more about the College’s U.S. advocacy efforts. DON’T MISS THESE LATE-BREAKING CLINICAL TRIAL SESSIONS At ACC.17 you’ll see the latest practice-changing scientific breakthroughs featured during five Late-Breaking Clinical Trial Sessions and three Featured Clinical Research Sessions. Plus, don’t miss two Deep Dive Sessions where you’ll find out what it all means for you and your patients! FRIDAY, MARCH 17 ACC.17 Opening Showcase and the Joint ACC/JACC Late-Breaking Clinical Trials Session 400 ACC.17 Main Tent, Hall D 8:00 – 10:00 a.m. • FOURIER: Primary Results of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial • SPIRE 1 and SPIRE 2: Safety and Cardiovascular Event Efficacy of Bococizumab Among 27,000 High Risk Patients • SURTAVI: Transcatheter Aortic Valve Replacement With a Self-Expanding Bioprosthesis Compared With Surgical Aortic Valve Replacement in Patients at Intermediate Surgical Risk: First Results From the SURTAVI Clinical Trial Featured Clinical Research I Session 401 Room 146B 12:15 – 1:45 p.m. • RESET-HCM: Testing Safety and Efficacy: The Randomized Exploratory Study of Exercise Training in Hypertrophic Cardiomyopathy • S2P Study: Results of MRI-Based Screening Study of 5130 Candidates for Sports Participation • MR-INFORM: Stress Perfusion Imaging to Guide the Management of Patients With Stable Coronary Artery Disease • Effects of Different Front-of-Pack Food Labeling Formats on the Healthiness of Food Purchases — a Randomized Trial • Native South American Tsimane Have the Lowest Levels of Coronary Atherosclerosis Ever Reported • ORION 1: LDL-C Reduction From 6 to 9 Months Following Single or Second Injection of Inclisiran a Novel siRNA Compound: Primary Efficacy and Safety Outcomes of the ORION 1 Trial SATURDAY, MARCH 18 Joint ACC/Journal of the American Medical Association Late- Breaking Clinical Trials Session 404 ACC.17 Main Tent, Hall D 8:00 – 9:15 a.m. • EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism • GEMINI-ACS-1: A Randomized Trial Evaluating Clinically Significant Bleeding With Low-Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, for Patients After Acute Coronary Syndromes • REACH: e-Counseling for Self-Care Adherence Adds Therapeutic Benefit for Hypertension: The REACH Trial • CARAT: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis: Results of the CARAT Study • EBBINGHAUS: Primary Results of EBBINGHAUS, a Cognitive Study of Patients Enrolled in the FOURIER Trial Late-Breaking Clinical Trials Session 405 ACC.17 Main Tent, Hall D 10:45 a.m. – Noon • COMPARE-ACUTE: FFR Guided Acute Complete Revascularization Versus Culprit Lesion Only Treatment in Patients Presenting With ST-Segment Elevation Myocardial Infarction and Multi Vessel Disease • DEFINE-FLAIR: Primary Results of DEFINE-FLAIR: A Multi-Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFR and FFR Decision-Making for Physiological Guided Coronary Revascularization • IFR-SWEDEHEART: Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention (IFR-SWEDEHEART): A Multicenter, Prospective, Registry-Based Randomized Clinical Trial • DECISION CTO: Drug- Eluting Stent Versus Optimal Medical Therapy in Patients With Coronary Chronic Total Occlusion: DECISION CTO Randomized Trial • ABSORB III: Everolimus- Eluting Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Disease: Two-Year Outcomes From the ABSORB III Trial Featured Interventional Clinical Research II Session 408 Room 201 12:30 – 1:45 p.m. • ADVICE Study: Real-World Comparative Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in the United States: An Analysis from Two US Registries Linked to Medicare Data • STS/ACC TVT Registry: Comparison of In-Hospital and 1-Year Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprosthesis Versus Native Aortic Stenosis From the STS/ACC TVT Registry • Procedural and Clinical Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis • RAD Matrix: Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RAD Matrix Study • Clinical Outcomes at 1-Year After Commercial Transcatheter Mitral Valve Repair in the United States Deep Dive I Session 406 Ballroom B 2:00 – 3:30 p.m. SUNDAY, MARCH 19 Joint ACC/New England Journal of Medicine Late-Breaking Clinical Trials Session 410 ACC.17 Main Tent, Hall D 8:00 – 9:15 a.m. • LEVO-CTS: Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery With Cardiopulmonary Bypass: Primary Results of the LEVO-CTS Trial • Cerebral Embolic Protection Devices During Surgical Aortic Valve Replacement: A Randomized Trial From the Cardiothoracic Surgical Trials Network • Silent Cerebral Microbleeds During TAVR: Insight From a Prospective Cerebral MRI Cohort • RESOLVE and SAVORY: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Aortic Valves: Results From RESOLVE and SAVORY Registries • VISION Study: Relationship Between High Sensitive Troponin T Measurements and 30-Day Mortality After Noncardiac Surgery Late-Breaking Clinical Trials Session 411 ACC.17 Main Tent, Hall D 10:45 a.m. – Noon • RE-CIRCUIT: Safety and Efficacy of Uninterrupted Anticoagulation With Dabigatran Etexilate Versus Warfarin in Patients Undergoing Catheter Ablation of Atrial Fibrillation: The RE-CIRCUIT Study • ARISTOTLE: Digoxin and Mortality in Patients With Atrial Fibrillation With and Without Heart Failure: Does Serum Digoxin Concentration Matter? • Comparative Effectiveness of Left Atrial Appendage Occlusion Among Atrial Fibrillation Patients Undergoing Cardiac Surgery: A Report From the Society of Thoracic Surgeons Adult Cardiac Surgery Database • GIFT of Warfarin: Benefit of Pharmacogenetic Dosing • SPAIN Study: Randomized Placebo Controlled Trial of Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope Featured Clinical Research III Session 415 Room 150A 2:00 – 3:30 p.m. • Early Challenges for PSCK9 Inhibitor Prescriptions and Patients: Rejections and Rates Unfilled • STOMP: The Effect of High-Dose Atorvastatin on Neuronal Activity and Cognitive Function • Outcomes for 15,259 US Patients With Acute MI Cardiogenic Shock (AMICS) Supported With Impella • CVD-REAL Study: Lower Rates of Hospitalization for Heart Failure in New Users of SGLT-2 Inhibitors Versus Other Glucose Lowering Drugs — Real-World Data From Four Countries and More Than 360,000 Patients: The CVD-REAL Study • Paroxysmal Atrial Fibrillation Is Associated With Worse Clinical Outcomes Than Persistent/Permanent Atrial Fibrillation in Patients With Heart Failure and Reduced Ejection Fraction • Reduction in Heart Failure Hospitalizations With Ambulatory Hemodynamic Monitoring Seen in Clinical Trials Is Maintained in the ‘Real World’ Deep Dive II Session 413 Ballroom B 12:30 – 1:45 p.m. ACC.17: SOMETHING FOR EVERYONE CONVOCATION WILL RECOGNIZE NEW CLASS OF FACCs AND AACCs After three days of the latest in cardiovascular research, interactive sessions and networking, ACC.17 will close with the time-honored tradition of Convocation. Presided over by the outgoing ACC president, the 66th Annual Convocation Ceremony will usher in the newest class of ACC Fellows and Associates, recognize award winners and welcome new ACC leaders. Convocation will take place on March 19, at 6:30 p.m., followed by the President’s, New Fellows’ and Associates Reception. Building community and providing each member of the cardiovascular care team with knowledge that can be used to enhance their respective roles in cardiovascular care is a guiding principle for ACC.17. As such, ACC.17 has something for everyone. Don’t miss the following programming targeted at Fellows in training (FITs) and Early Career professionals, International attendees and members of the cardiovascular team (CV Team). Also, new this year, don’t miss the All Sections Reception taking place on Saturday, March 18 at 6:30 p.m. at the Marriot Marquis. FIT AND EARLY CAREER PROFESSIONAL MEMBERS: Special programming for FITs and Early Career members is designed to support career development and understanding of the changing health care environment. On Friday, FITs can take part in the popular FIT Forum Mix and Mingle, as well as Stump the Professor. Saturday FIT Forums are focused on scholarship and education, as well as what FITs need to know to launch a successful career. The second annual FIT Jeopardy: Battle of the State Chapters competition will be held on Friday and Saturday. FITs interested in interventional cardiology shouldn’t miss the special Fellows Bootcamp sessions taking place on Sunday. Early Career professionals can learn from experts and test their skills in sessions focused on case studies from the guidelines, “launching and growing” an academic medical career, social media and cardiovascular professionals, and an “inside Look into JACC and peer-reviewed publishing.” In addition, a special session focused on “Mentoring the Care Team” is designed for FITs, Early Career and CV Team Members. CV TEAM MEMBERS: Evidence increasingly indicates that when patient care is managed by a team, outcomes improve. ACC.17 offers a diverse and innovative interdisciplinary program that showcases the positive impact of participation of the entire cardiovascular care team. CV Team members can take part in “CV Team Cases” (moderated poster sessions highlighting collaboration with interdisciplinary colleagues), as well as sessions addressing multidisciplinary approaches to controversies in cardiology and imaging. Other sessions are focused on redesigning a care delivery team in preparation for the Medicare and CHIP Reauthorization Act (MACRA), as well as lifestyle strategies for patients with adult congenital cardiology, diabetes, ASCVD and more. INTERNATIONAL MEMBERS: More than 25 international programs with representation by 38 international societies will take place during ACC.17. Multiple joint international society programs, including two with the European Society of Cardiology, will address topics of importance to the global cardiovascular community. Also not to miss, the 16th Annual Maseri-Florio International Lecture, featuring Huon Gray, MD, FACC, taking place on Saturday. New this year, International attendees can earn ECME credit. Attendees can get a jump on ACC.17 global activities at two special symposia – the 9th Annual Conference on the Middle East and Conquering Health Care Challenges in the Emerging World – both of which are on Thursday, March 16. The Middle East symposium will focus on the challenges and opportunities with improving heart health in the Middle East, with a special focus on hypertension and HfpEF. Meanwhile, the Conquering Health Care Challenges symposium will offer a closer look at the global importance of advocacy, as well as the impact of heart disease in women. DOWNLOAD THE ACC.17 APP Make the most out of ACC.17 with instant access to sessions, abstracts, exhibitors, maps and more. Browse sessions by day, pathway or practice focus and build a personalized itinerary. Seamlessly claim credit or get a certificate of participation, access live streaming sessions, download session slides (24 hours after each presentation), get the latest news via ACC’s twitter feed, and more. Search “ACC.17” in the app store or browse the online meeting planner at ACCScientificSession.org.
Published by American College of Cardiology. View All Articles.
This page can be found at https://bluetoad.com/article/ACC.17%3A+Meaningful+Education+At+Its+Best/2731563/389870/article.html.